NW
PYXS icon

NewEdge Wealth’s Pyxis Oncology PYXS Stock Holding History

NewEdge Wealth’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Hold
116,006
– – ﹤0.01% 1094
2025
Q4 		$133K Hold
116,006
– – ﹤0.01% 1167
2025
Q3 		$454K Hold
116,006
– – 0.01% 780
2025
Q2 		$124K Hold
116,006
– – ﹤0.01% 947
2025
Q1 		$114K Sell
116,006
-3
-0% -$4 ﹤0.01% 914
2024
Q4 		$181K Buy
116,009
+3
+0% +$9 ﹤0.01% 888
2024
Q3 		$426K Buy
+116,006
New +$406K 0.01% 654

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Wealth's PYXS Position: Q1 2026 in Review

NewEdge Wealth held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 116,006 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

NewEdge Wealth first reported a position in PYXS in Q3 2024 and has held it in 7 quarters since. The position peaked at $454K in Q3 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • NewEdge Wealth held 116,006 shares of Pyxis Oncology worth $169K as of Q1 2026.
  • NewEdge Wealth left its Pyxis Oncology share count unchanged in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of NewEdge Wealth's portfolio in Q1 2026, its #1094 holding.
  • NewEdge Wealth first reported a position in Pyxis Oncology in Q3 2024 and has held it in 7 quarters since.
  • NewEdge Wealth's Pyxis Oncology position peaked at $454K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.